Clinical TrialsSearch results
Number of results: 321
Other
- Japan endometrioma malignant transformation study
- endometriosis
- Japan Society of Obstetrics and Gynecology
- 2009-04-13
Recruiting
- Study on prevention of hypercapnia by Nasal High Flow in patients with endoscopic submucosal dissection during intravenous anesthesia
- Esophagus cancer, Gastric cancer, Colorectal cancer
- Ayuse Takao
- 2019-08-26
Other
- The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS)
- Essential hypertension
- JATOS Study Group
- 2008-02-15
Other
- Gene evaluation for antihypertensive drug effects study
- essential hypertension
- National Cardiovascular Center
- 2005-09-07
Recruiting
- Phase II study of IRInotecan after COmbined immunotherapy for extensive-disease small cell lung cancer
- Extensive-disease small cell lung cancer
- Mukae Hiroshi
- 2021-11-04
Other
- Gene analysis associated with short stature and growth hormone responsiveness
- famirial short stature, idopathic short stature, Noonan syndrome, and good/poor respoders of growth hormone therapy
- Keio University, School of Medicine
- 2006-12-01
Other
- The efficacy and feasibility of the repeated intraperitoneal Paclitaxel +systemic TS-1 and Paclitaxel for far advanced or recurrent gastric cancer: Phase I/II trial.
- Far advanced or recurrent gastric cancer
- Department of Surgical Oncology The University of Tokyo
- 2008-08-30
Other
- Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematologic diseases (C-SHOT 0402 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2005-08-29
Other
- Phase II study of micafungin as empirical antifungal therapy for febrile neutropenic patients (C-SHOT 0503 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2006-03-30
Other
- Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-II: Multicenter phase II clinical trial for children with non-T-ALL in intermediate risk group stratified by the minimal residual disease (MRD).
- first relapsed acute lymphoblastic leukemia in children
- Japanese Peditric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-06-01